TIRAP C539T polymorphism contributes to tuberculosis susceptibility: Evidence from a meta-analysis

Infection, Genetics and Evolution

Volumn 27, Issue , 2014, Pages 32-39

  Liu, Qianqian ^a   Li, Wenzhang ^b   Li, Dongdong ^a   Feng, Yulin ^a   Tao, Chuanmin ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU MEDICAL COLLEGE   (China)

Author keywords

MAL; Meta analysis; Polymorphism; TIRAP; Tuberculosis

Indexed keywords

ADAPTOR PROTEIN; TOLL INTERLEUKIN 1 RECEPTOR DOMAIN CONTAINING ADAPTOR PROTEIN; UNCLASSIFIED DRUG; INTERLEUKIN 1 RECEPTOR; MEMBRANE PROTEIN; TIRAP PROTEIN, HUMAN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INFECTION RISK; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK REDUCTION; TUBERCULOSIS; ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; ODDS RATIO; PUBLISHING; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MEMBRANE GLYCOPROTEINS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RECEPTORS, INTERLEUKIN-1; TUBERCULOSIS;

EID: 84904363482     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.06.025     Document Type: Article

References (33)

1. Bernard N.J., O'Neill L.A. Mal, more than a bridge to MyD88. IUBMB Life 2013, 65:777-786.
2. Boechat A.L., Ogusku M.M., Sadahiro A., dos Santos M.C. Association between the PTPN22 1858C/T gene polymorphism and tuberculosis resistance. Infect. Genet. Evol. 2013, 16:310-313.
3. Brites D., Gagneux S. Old and new selective pressures on Mycobacterium tuberculosis. Infect. Genet. Evol. 2012, 12:678-685.
4. Capparelli R., De Chiara F., Di Matteo A., Medaglia C., Iannelli D. The MyD88 rs6853 and TIRAP rs8177374 polymorphic sites are associated with resistance to human pulmonary tuberculosis. Genes Immun. 2013, 14:504-511.
5. Castiblanco J., Varela D.C., Castano-Rodriguez N., Rojas-Villarraga A., Hincapie M.E., Anaya J.M. TIRAP (MAL) S180L polymorphism is a common protective factor against developing tuberculosis and systemic lupus erythematosus. Infect. Genet. Evol. 2008, 8:541-544.
6. DerSimonian R., Laird N. Meta-analysis in clinical trials. Controlled Clin. Trials 1986, 7:177-188.
7. Dissanayeke S.R., Levin S., Pienaar S., Wood K., Eley B., Beatty D., Henderson H., Anderson S., Levin M. Polymorphic variation in TIRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groups. PloS One 2009, 4:e6698.
8. Duval S., Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
9. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315:1533-1537.
10. Ferwerda B., Alonso S., Banahan K., McCall M.B., Giamarellos-Bourboulis E.J., Ramakers B.P., Mouktaroudi M., Fain P.R., Izagirre N., Syafruddin D., Cristea T., Mockenhaupt F.P., Troye-Blomberg M., Kumpf O., Maiga B., Dolo A., Doumbo O., Sundaresan S., Bedu-Addo G., van Crevel R., Hamann L., Oh D.Y., Schumann R.R., Joosten L.A., de la Rua C., Sauerwein R., Drenth J.P., Kullberg B.J., van der Ven A.J., Hill A.V., Pickkers P., van der Meer J.W., O'Neill L.A., Netea M.G. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:10272-10277.
11. Gong T., Yang M., Qi L., Shen M., Du Y. Association of MCP-1 -2518A/G and -362G/C variants and tuberculosis susceptibility: a meta-analysis. Infect. Genet. Evol. 2013, 20:1-7.
12. Hawn T.R., Dunstan S.J., Thwaites G.E., Simmons C.P., Thuong N.T., Lan N.T., Quy H.T., Chau T.T., Hieu N.T., Rodrigues S., Janer M., Zhao L.P., Hien T.T., Farrar J.J., Aderem A. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis. 2006, 194:1127-1134.
13. Horne D.J., Randhawa A.K., Chau T.T., Bang N.D., Yen N.T., Farrar J.J., Dunstan S.J., Hawn T.R. Common polymorphisms in the PKP3-SIGIRR-TMEM16J gene region are associated with susceptibility to tuberculosis. J. Infect. Dis. 2012, 205:586-594.
14. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002, 420:329-333.
15. Khor C.C., Chapman S.J., Vannberg F.O., Dunne A., Murphy C., Ling E.Y., Frodsham A.J., Walley A.J., Kyrieleis O., Khan A., Aucan C., Segal S., Moore C.E., Knox K., Campbell S.J., Lienhardt C., Scott A., Aaby P., Sow O.Y., Grignani R.T., Sillah J., Sirugo G., Peshu N., Williams T.N., Maitland K., Davies R.J., Kwiatkowski D.P., Day N.P., Yala D., Crook D.W., Marsh K., Berkley J.A., O'Neill L.A., Hill A.V. A mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet. 2007, 39:523-528.
16. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J. Clin. Epidemiol. 2009, 62:e1-e34.
17. Liu G., Li G., Xu Y., Song N., Shen S., Jiang D., Zeng W., Wang H. Association between IL12B polymorphisms and tuberculosis risk: a meta-analysis. Infect. Genet. Evol. 2014, 21:401-407.
18. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 1959, 22:719-748.
19. Miao R., Li J., Sun Z., Xu F., Shen H. Meta-analysis on the association of TIRAP S180L variant and tuberculosis susceptibility. Tuberculosis 2011, 91:268-272.
20. Nagpal K., Plantinga T.S., Wong J., Monks B.G., Gay N.J., Netea M.G., Fitzgerald K.A., Golenbock D.T. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling. J. Biol. Chem. 2009, 284:25742-25748.
21. Nejentsev S., Thye T., Szeszko J.S., Stevens H., Balabanova Y., Chinbuah A.M., Hibberd M., van de Vosse E., Alisjahbana B., van Crevel R., Ottenhoff T.H., Png E., Drobniewski F., Todd J.A., Seielstad M., Horstmann R.D. Analysis of association of the TIRAP (MAL) S180L variant and tuberculosis in three populations. Nat. Genet. 2008, 40:261-262. (author reply 262-263).
22. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 2007, 7:353-364.
23. Rosman M.D., Oner-Eyupoglu A.F. Clinical Presentation and Treatment of Tuberculosis. Fishman's Pulmonary Diseases and Disorders 1998, 2483-2502. McGraw-Hill. A.P. Fishman (Ed.).
24. Sanchez D., Lefebvre C., Rioux J., Garcia L.F., Barrera L.F. Evaluation of Toll-like receptor and adaptor molecule polymorphisms for susceptibility to tuberculosis in a Colombian population. Int. J. Immunogenet. 2012, 39:216-223.
25. Selvaraj P., Harishankar M., Singh B., Jawahar M.S., Banurekha V.V. Toll-like receptor and TIRAP gene polymorphisms in pulmonary tuberculosis patients of South India. Tuberculosis 2010, 90:306-310.
26. Sheedy F.J., O'Neill L.A. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling. J. Leukocyte Biol. 2007, 82:196-203.
27. Taype C.A., Shamsuzzaman S., Accinelli R.A., Espinoza J.R., Shaw M.A. Genetic susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infect. Genet. Evol. 2010, 10:495-504.
28. Tobin D.M., Roca F.J., Oh S.F., McFarland R., Vickery T.W., Ray J.P., Ko D.C., Zou Y., Bang N.D., Chau T.T., Vary J.C., Hawn T.R., Dunstan S.J., Farrar J.J., Thwaites G.E., King M.C., Serhan C.N., Ramakrishnan L. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 2012, 148:434-446.
29. Wells, G., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available:. Accessed 27 February 2014. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
30. World Health Organization (2013) Global tuberculosis report 2013. Available:. Accessed 27 February 2014. http://www.who.int/tb/publications/global_report/en/index.html.
31. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., Takeda K., Akira S. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329.
32. Yang Y., Li X., Cui W., Guan L., Shen F., Xu J., Zhou F., Li M., Gao C., Jin Q., Liu J., Gao L. Potential association of pulmonary tuberculosis with genetic polymorphisms of toll-like receptor 9 and interferon-gamma in a Chinese population. BMC Infect. Dis. 2013, 13:511.
33. Zhang Y.X., Xue Y., Liu J.Y., Zhao M.Y., Li F.J., Zhou J.M., Wang H.J., Li J.C. Association of TIRAP (MAL) gene polymorphisms with susceptibility to tuberculosis in a Chinese population. Genet. Mol. Res. 2011, 10:7-15.